Announced Fri, 6 Nov, 2026 · 10:25 IST
Kayan acquires 5.67% of Wardwizard through convertible warrants
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction
Awaiting price reaction for this filing.
AI summary
Kayan Investment & Trading Company, a non-promoter, acquired 630,000 fully convertible warrants in Wardwizard Healthcare on 4 November 2026 through preferential allotment. Each warrant costs Rs 10 and converts into one Rs 10 equity share. Kayan paid 25 percent upfront; the balance is due when the warrants are exercised within 18 months. The warrants represent 5.67 percent of diluted capital.
Likely market impact
May signal new investor interest, but conversion would dilute existing holders and could create future selling pressure if Kayan sells the shares.